Class IV Ca2+ antagonists do not affect lipid peroxidation in singlet oxygen challenged cardiomyocytes

Cell Biol Int Rep. 1990 Apr;14(4):399-406. doi: 10.1016/0309-1651(90)91209-m.

Abstract

The effects of various Ca2+ antagonists on lipid peroxidation in singlet O2-challenged isolated cardiomyocytes from adult rat heart were investigated. Singlet O2-challenged untreated cells all hypercontracted as a consequence of Ca2+ overload and produced 463.6 +/- 143.6 nM malondialdehyde (MDA; mean +/- SD, n = 8). Protective Ca2+ antagonists reduced the amount of damaged cells, but did generally not affect MDA production. On the other hand, free radical scavengers and antioxidants displayed a good correlation between number of protected cells and MDA produced. It is concluded that flunarizine-like Ca2+ antagonists protect cells against Ca2+ overload without, however, interfering with peroxidative processes.

MeSH terms

  • Animals
  • Benzothiazoles
  • Calcium Channel Blockers / pharmacology*
  • Cell Separation
  • Cinnarizine / pharmacology
  • Diltiazem / pharmacology
  • Flunarizine / pharmacology
  • Lidoflazine / pharmacology
  • Lipid Peroxidation / drug effects*
  • Malondialdehyde / metabolism
  • Myocardium / cytology*
  • Myocardium / metabolism
  • Nicardipine / pharmacology
  • Oxygen / pharmacology*
  • Piperidines / pharmacology
  • Rats
  • Thiazoles / pharmacology
  • Verapamil / pharmacology

Substances

  • Benzothiazoles
  • Calcium Channel Blockers
  • Piperidines
  • Thiazoles
  • Cinnarizine
  • Malondialdehyde
  • R 56865
  • Verapamil
  • Nicardipine
  • Diltiazem
  • Lidoflazine
  • Flunarizine
  • Oxygen